Table 5 Effect of the multidisciplinary structured lifestyle intervention on estimated 10-year risk of cardiovascular events, general health and quality of life among patients with stable cardiovascular disease compared with usual care at baseline, and at 3 and 6 months
Secondary outcome measures | Baseline | Â | 3 months | Â | 6-months | Â |
|---|---|---|---|---|---|---|
|  | Intervention n = 71 | Control n = 75 | Intergroup differencesaB(95% CI) | p | Intergroup differencesaB(95% CI) | p |
10-year risk cardiovascular event a | Â | Â | Â | Â | Â | Â |
Coronary heart disease | 37.3 (20.3) | 33.8 (18.8) | −0.6 (−3.4/2.2) | 0.67 | −0.6 (−4.3/3.1) | 0.75 |
Myocardial infarction | 18.9 (13.9) | 17.1 (11.6) | −1.1 (−3.0/0.9) | 0.29 | −0.8 (−3.5/1.8) | 0.53 |
Cerebrovascular accident | 8.2 (8.0) | 7.3 (6.1) | −0.5 (−1.5/0.4) | 0.26 | −0.3 (−1.4/0.9) | 0.66 |
Total mortality | 35.0 (18.1) | 34.1 (17.1) | 0.2 (−2.6/3.0) | 0.89 | 1.1 (−1.6/3.8) | 0.43 |
General health and quality of life | Â | Â | Â | Â | Â | Â |
SF-36 MCS | 52.9 (9.8) | 52.2 (11.0) | 0.6 (−1.6/2.9) | 0.58 | −0.8 (−3.1/1.5) | 0.50 |
   PCS | 39.6 (10.6) | 42.2 (9.5) | 1.6 (−1.0/4.1) | 0.23 | 1.0 (−1.7/3.7) | 0.47 |
MacNew b | 5.3 (0.8) | 5.2 (0.9) | 0.06 (−0.1/0.3) | 0.56 | 0.04 (−0.2/0.2) | 0.69 |
Vascuqol c | 4.8 (1.4) | 5.6 (0.9) | −0.09 (−0.9/0.7) | 0.81 | −0.2 (−1.7/1.3) | 0.78 |